换一批
换一批Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG.
第一作者：
D,Nitti
第一单位：
Università di Padova, Clinica Chirurgica II, Padova, Italy, and Laurentius Hospital, Roermond, The Netherlands. donato.nitti@unipd.it
作者：
主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);化学疗法, 辅助(Chemotherapy, Adjuvant);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);综合疗法(Combined Modality Therapy);无病生存(Disease-Free Survival);多柔比星(Doxorubicin);表柔比星(Epirubicin);女(雌)性(Female);氟尿嘧啶(Fluorouracil);人类(Humans);男(雄)性(Male);甲氨蝶呤(Methotrexate);中年人(Middle Aged);随机对照试验(主题)(Randomized Controlled Trials as Topic);胃肿瘤(Stomach Neoplasms);存活率分析(Survival Analysis)
DOI
10.1093/annonc/mdj077
PMID
16293676
发布时间
2020-02-03
- 浏览5
Annals of oncology
262-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
